Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Jeff Craven

News

Experts share early details prescribing avacopan for ANCA-associated vasculitis

Author:
Jeff Craven
Publish date: March 14, 2023

Rheumatologists said more data are needed to determine optimal glucocorticoid tapering and treatment duration of avacopan for patients with ANCA-...

  • Read More

News

Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritis

Author:
Jeff Craven
Publish date: March 8, 2023

While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well on both medications; however, cost and...

  • Read More

News

Expert offers caveats to perioperative antirheumatic drug guideline

Author:
Jeff Craven
Publish date: February 23, 2023

Experts say the 2022 ACR/AAHKS guideline on perioperative management of antirheumatic medications in total hip and total knee arthroplasty have a...

  • Read More

News

Adaptations to education, training vital to alleviating rheumatologist shortage

Author:
Jeff Craven
Publish date: February 23, 2023

Training the next generation of rheumatologists will involve giving and listening to more feedback as well as using new tools to boost engagement...

  • Read More

News

Telemedicine usage still high among rheumatologists as interest wanes in other specialties

Author:
Jeff Craven
Publish date: February 21, 2023

“For you to abandon telemedicine I think is a gigantic mistake,” Dr. Jack Cush said.

  • Read More

News

Are repeat radiographs necessary in rheumatoid and psoriatic arthritis?

Author:
Jeff Craven
Publish date: February 16, 2023

“If a patient doesn’t achieve remission or very low disease activity, obtaining a radiograph doesn’t change what you do because the patient’s not...

  • Read More

News

Remote electrical neuromodulation device helps reduce migraine days

Author:
Jeff Craven

The device decreased the number of migraine days by an average of 4 days per month.

  • Read More

News

Brepocitinib improves symptoms of mild to moderate AD in phase 2b trial

Author:
Jeff Craven
Publish date: November 28, 2022

In addition to AD, brepocitinib is currently being developed as a treatment for dermatomyositis, systemic lupus erythematosus, hidradenitis...

  • Read More

News

ICD-10 code can identify patients with melasma for future study

Author:
Jeff Craven
Publish date: November 10, 2022

“Overall, our results support the validity of using the ICD-10 code for melasma to identify patients with a diagnosis of melasma for future...

  • Read More

News

Immediate skin-to-skin contact after cesarean section improves outcomes for parent, newborn

Author:
Jeff Craven
Publish date: October 25, 2022

“One of the greatest take-home points from the study was that early skin-to-skin really promoted initiation of breastfeeding.”

  • Read More

News

Health care providers should have higher suspicion for rare diseases

Author:
Jeff Craven
Publish date: October 15, 2022

Learning to recognize when a cluster of symptoms doesn’t fit a pattern is important, as patients and their providers tend to gravitate toward...

  • Read More

News

Headache for inpatients with COVID-19 may predict better survival

Author:
Jeff Craven
Publish date: October 13, 2022

Headache arising secondary to COVID-19 infection may be a marker of enhanced likelihood of survival.

  • Read More

News

Body-brain neuroinflammation loop may cause chronic ME/CFS, long COVID symptoms

Author:
Jeff Craven

ME/CSF and long COVID are biologically based and involve ‘much disturbed physiology.’

  • Read More

News

Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD

Author:
Jeff Craven
Publish date: July 11, 2022

Compared with conventional treatment, the risk of developing nonpustular psoriasis was twofold higher among patients receiving TNFi treatment.

  • Read More

News

Therapeutic patient education can help with adherence to treatment

Author:
Jeff Craven
Publish date: June 9, 2022

Therapeutic patient education is recommended for children and adults with moderate to severe AD in the 2020 European Task Force on Atopic...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close